PLUS THERAPEUTICS, INC. logo

PLUS THERAPEUTICS, INC.

0001095981

Plus Therapeutics is a clinical-stage pharmaceutical company focusing on developing targeted radiotherapeutics for cancer treatment. They leverage novel drug formulations and technologies to deliver a single, safe, and effective dose of radiation directly to the tumor. Their focus is on improving the treatment of challenging cancers in adults and children, aiming to lengthen and improve lives.

75
Pålitelig
Tillitsscore

Offisielt Register

Foretaksnavn
PLUS THERAPEUTICS, INC.
Organisasjonsnummer
0001095981
MVA Nummer
330827593
Firmastatus
Active
Adresse
4200 MARATHON BLVD., AUSTIN, TX 78756
Bransjekoder
3841: Surgical & Medical Instruments & Apparatus

Sist verifisert: 1/2/2026

AI Kvalitetsanalyse

Bransje
Pharmaceuticals
SSL/HTTPS
Sikker
Profesjonell E-post
Nei

🌟 Lignende Pålitelige Bedrifter

Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals, Inc. logo
73/100 · Pålitelig

Anebulo Pharmaceuticals develops innovative therapies to improve the lives of patients struggling with unintentional cannabis poisoning and acute cannabinoid intoxication. They focus on developing best-in-class therapeutics for treating acute cannabinoid toxicities, particularly in children. The company prioritizes the development of Selonabant.

C/O ANEBULO PHARMACEUTICALS, USA
Se profil

OVATION SCIENCE INC.

OVATION SCIENCE INC. logo
74/100 · Pålitelig

Ovation Science Inc. leverages its patented Invisicare® technology to enhance the delivery of drugs and ingredients through the skin. They provide pharmaceutical-grade technology to global licensees, resulting in high-quality, efficacious topical and transdermal products. They are positioned as an innovative player in the drug development and cannabis industries.

1085 - 555 BURRARD STREET, USA
Se profil

SHIONOGI & CO LTD

SHIONOGI & CO LTD logo
75/100 · Pålitelig

Shionogi is a pharmaceutical company focused on research and development of innovative medicines. They are particularly committed to addressing antimicrobial resistance (AMR) and improving access to healthcare. Shionogi provides a wide range of pharmaceutical products and services, and is known for its research in infectious diseases and other therapeutic areas. The company has a long history and a strong commitment to sustainability.

1-8, USA
Se profil